Prot #HM-EMSI-202: A Single-Arm, Open-Label, Phase 2 Study Evaluating The Efficacy, Safety And Pharmacokinetics Of HM61713 In Patients With T790M-Positive Non-Small Cell Lung Cancer (NSCLC) After Treatment With An Epidermal Growth Factor Receptor-Tyrosine

Project: Research project

Status	Finished
Effective start/end date	1/26/16 → 1/26/19

Project Details